Picture of Neurosense Therapeutics logo

NRSN — Neurosense Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Neurosense Therapeutics Enters Into Capital On Demand Sales Agreement With Jonestrading Institutional Services

Aug 16 (Reuters) - Neurosense Therapeutics Ltd  NRSN.O :
    * NEUROSENSE THERAPEUTICS LTD:  ENTERED INTO CAPITAL ON
DEMAND
SALES AGREEMENT WITH JONESTRADING INSTITUTIONAL SERVICES LLC
    * NEUROSENSE THERAPEUTICS LTD: MAY OFFER AND SELL, FROM TIME
TO
TIME, ORDINARY SHARES OF UP TO GROSS SALE PROCEEDS $2.5 MILLION

Source text for Eikon:  ID:n0001213900-24-070239 
Further company coverage:  NRSN.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Neurosense Therapeutics

See all news